The Medicines Company (NASDAQ:MDCO) was one of the biggest decliners on the NASDAQ and hit a new yearly low of $23.53 during intra-day trading. The drop came after the company made a statement that it expects only low-single-digit percentage operating margins on the projects it has in its current backlog. The Medicines Company (NASDAQ:MDCO) shares after opening at $23.89 moved to $24.69 on last trade day and at the end of the day closed at $24.02. Company price to sales ratio in past twelve months was calculated as 2.26 and price to cash ratio as 4.12. The Medicines Company (NASDAQ:MDCO) showed a negative weekly performance of -16.86%.
Aegis Capital reaffirmed its Buy rating and $32 target price on Galectin Therapeutics, Inc. (NASDAQ:GALT) following news that results from the first cohort of its Phase 1 trial show that GR-MD-02 had an effect on biomarkers that suggest a therapeutic effect on fibrosis, inflammation, and cellular injury. Galectin Therapeutics Inc. (NASDAQ:GALT) shares fell -11.30% in last trading session and ended the day on $13.58. GALT return on assets is -314.50%. Galectin Therapeutics Inc. (NASDAQ:GALT) yearly performance is 295.92%.
Ophthotech Corp (NASDAQ:OPHT) CFO Bruce Peacock sold 6,137 shares of Ophthotech Corp stock in a transaction dated Monday, March 24th. The shares were sold at an average price of $34.77, for a total value of $213,383.49. Ophthotech Corp (NASDAQ:OPHT) shares moved down -5.45% in last trading session and was closed at $33.73, while trading in range of $33.50 – $35.84. Ophthotech Corp (NASDAQ:OPHT) year to date (YTD) performance is 4.27%.
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, on 31 march announced full financial results for fiscal year ended December 31, 2013. Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) weekly performance is -0.48%. On last trading day company shares ended up $6.20. Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) distance from 50-day simple moving average (SMA50) is 16.21%.